Company intelligence / Profile preview

Vector Oncology

Ownership: Private
Development stage: Other

Overview

A leader in oncology-focused health economics/outcomes research and real-world evidence generation via its comprehensive oncology data warehouse and Patient Care Monitor patient engagement/outcomes platform. Its Contract Research Organization division specialized in complex global oncology trials before being acquired by George Clinical in May 2017.

Therapeutic areas: Oncology
Industry: Contract Research Organization

Partnerships

Precision Health AI/SymphonyAIVarious top pharmaceutical companies as clients/service recipients

Beyond the preview

Go deeper on Vector Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vector Oncology.

Explore the full profile